InsidersTradesSigma
Discover the full insider trade history of ARGOS THERAPEUTICS INC, a listed equity based in United States. Shares are quoted on US US, under the oversight of SEC (Form 4). Market capitalisation: €3.4bn. The latest transaction was filed on 12 January 2016 (Attribution). Among the most active insiders: Abbey Jeffrey D. The full history is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
6 of 6 declarations
ARGOS THERAPEUTICS INC is a biopharmaceutical company focused on developing immunotherapies for the treatment of cancer and other diseases. It is listed on NASDAQ under the ticker ARGS.